Calendar

Aug
28
Wed
2019
PHIND Seminar
Aug 28 @ 11:00 am – 12:00 pm
PHIND Seminar

PHIND Seminar August

Mehmet Ozgun

“Extracellular Vesicles for Broad Applications in Medicine and Cancer”

About Mehmet O. Ozen, PhD

Dr. Ozen is a Postdoctoral Research Fellow at Canary Center for Cancer Early Detection / Radiology Department at Stanford University. He works with Prof. Utkan Demirci on simple solutions for complex problems in medicine, combining microfluidics and bioengineering principles. He received his BS and PhD in Bioengineering from Ege University.

Abstract

Extracellular vesicles (EVs) are lipid bi-layered nanoparticles shed from the cells that carry RNA, DNA, transmembrane and cytosolic proteins. The variety in EV size, cargo and origin attracted researchers to decipher the mechanisms that have been involved in packaging, secretion, uptake and roles of EVs on cells in vivo and in vitro, lightening the path for biomarker studies for diagnosis, prognosis, therapy and therapy monitoring. They are one of the many means that cells use to communicate with neighboring and distant cells and tissues. With improvements in next-generation sequencing technologies and increased resolution of mass spectrometry for proteomic analysis, EVs have been shown to take role in angiogenesis, epithelial-to-mesenchymal transition, stemness in cancer, malignancy, metastasis and drug resistance.

Although exosomes show unprecedented promising advantages over other biotargets in the circulation for clinical use, a major challenge rapidly emerging in the field of EV utilization for clinical and non-clinical applications is the absence of reproducible, inexpensive and robust tools for efficient sorting and isolation of EV populations at a high yield. The field lacks a clear consensus over an optimum approach or a tool for isolation of EVs avoiding contamination with many other proteins and such other biostructures and reproducible procedures for downstream analysis of EV cargo and content. Existing approaches for EV isolation include a variety of methods. Additionally, methods for the exosome-derived analyte isolation, library preparation for sequencing, and downstream analysis including genomic, proteomic and metabolic analysis are highly varied. Hence, there is a need for well-developed experimental tools, interlaboratory evaluations and in-depth descriptions of experimental steps and designs to ensure reliable, robust and reproducible experiments and tools.

In this talk, we will describe a new technique, i.e., Exosome Total Isolation Chip (ExoTIC), that is developed in our lab to isolate EVs and EV subpopulations from a variety of sample types including plasma and culture media. We will present further downstream genomic and proteomic analysis of these EVs focusing on applications in cancer and cardiovascular disorders.

Sep
18
Wed
2019
PHIND Symposium
Sep 18 all-day
Oct
16
Wed
2019
PHIND Seminar: ‘Progression of Clonal Hematopoiesis of Indeterminate Potential to Acute Myeloid Leukemia’
Oct 16 @ 11:00 am – 12:00 pm
PHIND Seminar: 'Progression of Clonal Hematopoiesis of Indeterminate Potential to Acute Myeloid Leukemia'

PHIND Seminar Series October: ‘Progression of Clonal Hematopoiesis of Indeterminate Potential to Acute Myeloid Leukemia’

Ravi Majeti, MD, Ph.D.

Professor of Medicine
Chief, Division of Hematology
Institute for Stem Cell Biology and Regenerative Medicine
Stanford University

Munzer Auditorium (B060), Beckman Center

11:00am-12:00pm – Seminar and Discussion
12:00pm-12:15pm – Reception (light refreshments provided)

RSVP Here: https://www.onlineregistrationcenter.com/register/222/page1.asp?m=298&c=39

ABSTRACT: Myeloid malignancies are cancers of the blood lineage including myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML) with more than 40,000 new diagnoses annually in the United States. These diseases cause significant morbidity and mortality due to associated bone marrow failure leading to anemia, bleeding, and infections, and are currently treated with targeted therapies, chemotherapy, and allogeneic bone marrow transplantation. Next generation DNA sequencing has determined the spectrum of mutations associated with these cancers and has found that most cases are associated with multiple mutations that cooperate to cause disease. In our prior studies, we determined that these mutations are serially acquired in clones of self-renewing pre-cancerous/pre-leukemic blood stem cells. Separate studies analyzed blood sequencing data from large cohorts of individuals without disease and found these pre-leukemic mutations occur in the general population with increasing frequency and incidence with age. As only a minor subset of these individuals eventually progressed to develop myeloid malignancy, this entity was termed clonal hematopoiesis of indeterminate potential (CHIP). One major issue with implications for the transition from health to disease is to understand what factors influence the progression from CHIP to myeloid malignancy. In order to investigate this question, we have developed models for CHIP/pre-leukemia through the CRISPR-mediated engineering of normal human blood stem and progenitor cells. By introducing mutations in the TET2 and ASXL1 genes that are commonly mutated in CHIP, we have established models for the cell intrinsic processes of progression to myeloid malignancy and are now poised to examine cell extrinsic processes that can affect such progression. Establishing these models is key to investigating measures to eventually prevent development of myeloid malignancy.

Nov
20
Wed
2019
PHIND Seminar Series – Kathryn Phillips, PhD @ LK101
Nov 20 @ 11:00 am – 12:00 pm
PHIND Seminar Series - Kathryn Phillips, PhD @ LK101

PHIND Seminar Series November: ‘ What You Always Wanted to Know about Economics, Payer Coverage, and Big Data for Precision Health – But Were Afraid to Ask’

Kathryn Phillips, Ph.D.
Professor of Health Economics
Founding Director of the UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS)
Department of Clinical Pharmacy
UCSF

Li Ka Shing Center, LK101
11:00am-12:00pm – Seminar and Discussion
12:00pm-12:15pm – Reception (light refreshments provided)
RSVP Here: https://www.onlineregistrationcenter.com/KathrynPhillips

ABSTRACT: Precision Health offers an opportunity to achieve “high value care” through innovative approaches. However, in order to fulfill this objective, we must demonstrate its economic value, someone must be willing to pay the costs, and there has to be data available to provide the needed evidence. In this talk, I will draw on my research over the past decade examining (1) how to measure the value of complex technologies such as Precision Health, (2) what payers cover and how they decide to provide coverage, and (3) how Big Data can be leveraged. I will also describe “lessons learned” about successful adoption from working with dozens of start-ups, VCs, and biotech companies. The talk will illustrate these issues using the case study of “liquid biopsy” – a potentially transformative technology that illustrates both the opportunities and challenges for Precision Health.

Feb
18
Tue
2020
PHIND Seminar – Almudena Espin Perez, PhD @ Beckman Center, Munzer Auditorium (B060)
Feb 18 @ 12:00 pm – 1:15 pm
PHIND Seminar - Almudena Espin Perez, PhD @ Beckman Center, Munzer Auditorium (B060)

PHIND Seminar Series: “Prediction of Future Lymphoma Development Based on DNA Methylation Profiles from Peripheral Blood”

 

Almudena Espin Perez, PhD
Postdoctoral Research Fellow
Biomedical Informatics
Stanford University

 

Beckman Center, Munzer Auditorium (B060)
12:00pm – 1:00pm Seminar & Discussion
1:00pm – 1:15pm Reception & Light Refreshments
RSVP here: https://www.onlineregistrationcenter.com/APerez

 

ABSTRACT

Subjects with Non-Hodgkin Lymphoma (NHL) have abnormal lymphocytes that multiply and accumulate to form tumors in the lymph nodes and other organs. Currently, there are no predictive models with high performance that can predict the risk of developing NHL.

We present a computational framework that accurately predicts future (up to 16 years) NHL from a signature based on DNA methylation profiles of peripheral blood samples. We studied differences in specific DNA methylation levels from blood samples between future NHL group and the control group (470 samples) from two prospective cohorts. We developed a predictive model using advanced artificial intelligence methods for NHL diagnosis based on a set of key CpG sites. The validation tests showed that our signature 1) predicts mainly “control” in an independent population of 656 healthy subjects, 2) predicts “future case” with extremely accurate performance in tissue samples from four independent  NHL cohorts (662, 29, 31 and 29 subjects), with one of the cohorts (662 subjects) corresponding to children with B-cell lymphoma, 3) predicts mostly healthy in a cohort of children with 74 children in remission, 4) works for both HIV positive subjects and HIV negative subjects, 5) yields almost perfect predictions regardless of the NHL subtype, and 6) is 84% accurate at predicting T-cell lymphoma in children, despite its derivation in B-cell lymphoma in adults.

ABOUT
Almudena Espin Perez’s interests include developing algorithms and novel computational methods for early cancer detection. High-throughput technologies in the field of molecular biology are generating huge amounts of biological data and transforming the scientific landscape. A major focus of her research is on building computational methods to 1) study genomics and epigenetic data 2) integrate genomics and imaging data at single-cell level resolution and 3) leverage existing large-scale transcriptomic datasets to address relevant biological questions by developing computational deconvolution tools to infer the abundance of different cell types from mixed cell populations. Dr. Perez aims to improve the understanding of the molecular mechanisms behind cancer development, which could potentially lead to biomarker discovery and improve early detection, treatment strategies and decision-making.

 

Hosted by: Sanjiv Sam Gambhir, M.D., Ph.D.
Sponsored by the PHIND Center and the Department of Radiology

Mar
17
Tue
2020
CANCELLED – PHIND Seminar – Orestis Vardoulis, Ph.D. @ CANCELLED
Mar 17 @ 11:00 am – 12:00 pm
CANCELLED - PHIND Seminar - Orestis Vardoulis, Ph.D. @ CANCELLED

Please note this seminar is now cancelled and will be rescheduled for a future date. Please contact Ashley Williams (ashleylw@stanford.edu) with any questions or concerns. Thank you for your understanding!

 

PHIND Seminar Series: “A Stroke Monitoring and Alert System for a Future Without Late Presentation”

Orestis Vardoulis, Ph.D.
Postdoctoral Research Fellow
Pediatric Surgery
Stanford University

Apr
21
Tue
2020
PHIND Seminar – Kevin Schulman, MD @ Zoom - See Event Details for Link
Apr 21 @ 11:00 am – 12:00 pm
PHIND Seminar - Kevin Schulman, MD @ Zoom - See Event Details for Link

PHIND Seminar Series: The Behaviorome in Precision Medicine

Kevin Schulman, M.D.
Professor of Medicine (Hospital Medicine) and, by courtesy, of Economics a the Graduate School of Business

Stanford University

12:00pm – 1:00pm Seminar & Discussion
RSVP here: https://www.onlineregistrationcenter.com/KevinSchulman

 

Meeting URL: https://stanford.zoom.us/j/514973612
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
Meeting ID: 514 973 612

 

ABSTRACT
The revolution in biomedical technology that is allowing us to develop the concept of precision medicine has a fatal flaw. Medical science has focused on risk prediction in the hopes of using risk information to influence health behaviors. However, there is little evidence to support the notion that risk information alone influences individual behavior at scale. Concurrent with the development of the field of precision medicine is an even larger revolution in understanding of the behavior of populations using digital technology. Marketing, the science underlying these advances, offers tools and insights to help guide our understanding of how to translate risk information into behavior change. To date, marketing has been used for mass-customization of products and services outside of clinical medicine. For example, each of us has the opportunity to enjoy streaming video programs that suit our tastes and desires. This delightful consumer experience developed in an iterative fashion based on tight linkages between prediction and behavior. In this case, data are used to develop population segments that are likely to respond similarly to movie suggestions. In this talk, we’ll discuss how a better understanding of behavior in the health care realm, the Behaviorome, will help solve the last mile problem of Precision Medicine.

ABOUT

Dr. Schulman serves as Professor of Medicine, Associate Chair of Business Development and Strategy in the Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Economics at Stanford’s Graduate School of Business.

Dr. Schulman’s research interests include organizational innovation in health care, health care policy and health economics. With over 300 original articles, 90 review articles/commentaries, and 40 case studies/book chapters, Kevin Schulman has had a broad impact on health policy (h-index = 61). His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Health Policy, Management and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Services Research.

At Duke’s Fuqua School of Business, Dr. Schulman oversaw the growth of the health sector management program, graduating almost 1500 students. He is the Founding Director of the unique Master of Management in Clinical Informatics program (MMCi), originally offered through the Fuqua School of Business and now housed in the Duke University School of Medicine. He has served as a Visiting Professor in General Management at Harvard Business School from 2013-2016, and a visiting scholar from 2016-2018. At Stanford, he teaches a course on Health IT and Strategy at the GSB.

He is the Founding President of the Business School Alliance for Health Management (http://www.BAHM-Alliance.Org), which is a consortium of the leading business schools offering health management programs.

He is an elected member of ASCI and AAP.

 

Hosted by: Sanjiv Sam Gambhir, M.D., Ph.D.
Sponsored by the PHIND Center and the Department of Radiology

May
19
Tue
2020
PHIND Seminar – Akshay Chaudhari, Ph.D. @ Zoom - See Description for Zoom Link
May 19 @ 11:00 am – 12:00 pm
PHIND Seminar - Akshay Chaudhari, Ph.D. @ Zoom - See Description for Zoom Link

PHIND Seminar Series: Moving Magnetic Resonance Imaging Towards a Low-Cost High-Value Medical Imaging Modality

Akshay Chaudhari, Ph.D.
Instructor

Department of Radiology

Stanford University

12:00pm – 1:00pm Seminar & Discussion
RSVP Here: https://www.onlineregistrationcenter.com/AChaudhari

 

The seminar will be available via a zoom live stream. 

Meeting URL: https://stanford.zoom.us/j/257831873
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
Meeting ID: 257 831 873

 

ABSTRACT
Magnetic Resonance Imaging (MRI) is a medical imaging modality that offers exquisite resolution and soft-tissue contrast. It is an integral component in diagnostic radiology as well as in basic science research studies due its sensitivity in detecting subtle variations in tissue structure. While MRI can provide a rich source of information, typical acquisition times of 30-40 minutes can limit further widespread use, increase costs, and diminish the patient experience. Moreover, the high-resolution and multi-dimensional MRI datasets can also cause a challenge for efficient and accurate image interpretation. In this talk, through specific examples in musculoskeletal MRI, I will cover recent advances in MRI aided by classical engineering techniques as well as deep learning to substantially reduce the duration of MRI exams and for subsequent image analysis. I will describe how these efforts are helping change the paradigm of MRI by reducing costs and increasing efficiency.

 

ABOUT

Dr. Akshay Chaudhari is an Instructor in the Radiological Sciences Lab (RSL) and Precision Health and Integrated Diagnostics (PHIND) sections in department of Radiology who works at the interface of radiology and artificial intelligence. His research interests include developing efficient and safer medical imaging acquisition techniques, repeatable and accurate image analysis tools, and on multi-modality sensor fusion. He graduated with honors with a B.S. in Bioengineering from the University of California San Diego in 2012 and  completed his Ph.D. from Stanford Bioengineering in 2017 focusing on novel MRI methods to perform rapid quantitative musculoskeletal imaging. Dr Chaudhari received the National Science Foundation Graduate Research Fellowship, the Whitaker Fellowship, and the Siebel Fellowship to support his doctoral research. Dr. Chaudhari is the winner of the ISMRM W.S. Moore Young Investigator Award, and has won 6 additional young investigator awards for his work on advanced medical imaging acquisition and analysis techniques, and is a Junior Fellow of the ISMRM.

 

Hosted by: Sanjiv Sam Gambhir, M.D., Ph.D.
Sponsored by the PHIND Center and the Department of Radiology

Jun
16
Tue
2020
PHIND Seminar – Anoop Rao, M.D. & Eric Dy, Ph.D. @ Zoom - See Description for Zoom Link
Jun 16 @ 11:00 am – 12:00 pm
PHIND Seminar - Anoop Rao, M.D. & Eric Dy, Ph.D. @ Zoom - See Description for Zoom Link

PHIND Seminar Series

 

11:00-11:30 AM | Dr. Anoop Rao, M.D., M.S.
“Wearable Sensing for Neonates”

Clinical Instructor, Pediatrics (Neonatology)

Lucile Packard Children’s Hospital

Stanford University School of Medicine

 

11:30-12:00 PM | Dr. Eric Dy, Ph.D.
“Crowdsourced data and machine learning to design the future of prenatal care”

Co-founder and CEO

Bloomlife

 

12:00pm – 1:00pm Seminar & Discussion
RSVP Here: https://www.onlineregistrationcenter.com/PHIND061620

This seminar will be available in person and via a Zoom live stream.
Meeting URL: https://stanford.zoom.us/j/92848236311
Dial: +1 650 724 9799  or +1 833 302 1536
Meeting ID: 928 4823 6311

 

Dr. Anoop Rao Bio
Anoop Rao is a Clinical Instructor in Pediatrics (Division of Neonatology) at the Lucile Packard Children’s Hospital. After completing early medical training in India, he obtained his MS from MIT, and completed clinical training in Pediatrics from Columbia and fellowships in Neonatal Critical Care from Stanford and Biomedical Informatics from Harvard. He spent over 5 years at AgaMatrix, a startup focused on developing high-accuracy blood glucose meters.

At Stanford, his research is on contact and non-contact monitoring of infants. Anoop collaborates extensively with industry and is actively supported by NIH/Maternal and Child Health Research Institute.

Dr. Eric Dy Bio
Eric Dy, PhD is co-founder and CEO of Bloomlife, a women’s health company designing remote prenatal care solutions to improve the health of women and babies.  Eric brings unique perspective on the opportunities and challenges in emerging healthcare technologies and delivery models informed by multidisciplinary technical expertise leading business development for Europe’s leading R&D institute, imec. Eric earned his BSc in Bioengineering from Cornell and his MSc and PhD in Biomedical Engineering from UCLA.  Bloomlife has been recognized for their pioneering work winning Fast Company World Changing Ideas, Johnson & Johnson Quickfire Challenge, Richard Branson’s Extreme Tech Challenge, MedTech Innovator Award, and speaking at the White House Precision Public Health Summit.

Dr. Eric Dy Abstract
The period from conception through the first 1000 days of life are the most critical for lifelong health and development, yet too often we are failing women and babies at this time.  High risk pregnancies are on the rise, access to care is increasingly a problem, and pregnancy complications such as preterm birth now affect 1 in 10 babies.   Despite these growing challenges, the way we deliver prenatal care has not fundamentally changed in over 60 years.  We need smarter tools, better data, and scalable solutions to improve the health of moms and babies globally.

In this talk Bloomlife co-founder and CEO will share their strategy for designing the future of prenatal care.  He will discuss how clinical grade wearables, in the hands of mom, has helped create the largest dataset on pregnancy in the world, and how AI applied to this dataset is seeding breakthrough screening and diagnostic tools to help solve global maternal health issues including preterm birth.

Hosted by: Sanjiv Sam Gambhir, M.D., Ph.D.
Sponsored by: PHIND Center, Department of Radiology and eWEAR Initiative

Jul
21
Tue
2020
PHIND Seminar – Vishnu Shankar @ Zoom - See Description for Zoom Link
Jul 21 @ 11:00 am – 12:00 pm
PHIND Seminar - Vishnu Shankar @ Zoom - See Description for Zoom Link

PHIND Seminar Series: What is in your sweat and what can it mean for health and disease?
11:00 AM – 12:00 PM: Seminar & Discussion
RSVP: https://www.onlineregistrationcenter.com/VShankar

 

Presenter:
Vishnu Shankar, M.S.
Department of Chemistry
Stanford University

 

Principal Investigators:
Michael Snyder, Ph.D.
Stanford W. Ascherman, MD, FACS Professor in Genetics
Stanford University

Robert Tibshirani, Ph.D.
Professor of Biomedical Data Science and of Statistics
Stanford University

Richard Zare, Ph.D.
Marguerite Blake Wilbur Professor in Natural Science and Professor, by courtesy, of Physics
Stanford University

Location
Webinar URL: https://stanford.zoom.us/s/99817512229?pwd=QitCTjRXMEdBTWZyd29MTHYyNU5Xdz09
Dial: +1 650 724 9799  or +1 833 302 1536
Webinar ID: 998 1751 2229
Password: 489011

 

ABSTRACT

Sweat is a complex fluid known to be rich in electrolytes, small molecules, and fatty acids. Although adults can sweat up to 10 liters per day, little is still known about the chemical composition of sweat, how this changes, and what are its implications for health and disease. We demonstrate a powerful approach to help elucidate this link, where collecting samples simply requires swabbing a glass slide across one’s forehead in less than 30 seconds. Using the combination of desorption electrospray ionization mass spectrometry and statistical machine learning, our approach can successfully detect over 10,000 metabolites in sweat and identify metabolic changes in the sweat profile related to gender, age, and disease. As an example, we demonstrate in a cohort of 65 subjects the possibility of using just a few metabolites detected in sweat to successfully identify patients with renal disease. More generally, our approach suggests the possibility of using the sweat profile to non-invasively assess individual risk for metabolic diseases in the theme of “Precision Medicine.”

 

ABOUT VISHNU SHANKAR

Vishnu Shankar recently graduated with his master’s degree in computer science, with a specialization in artificial intelligence from Stanford University. He completed his bachelor’s degree with honors in mathematical and computational sciences in 2018, also at Stanford, with his senior thesis on Bayesian networks for incorporating effect modifiers in meta-analysis.  In addition, his background spans biology, mathematics, chemistry, statistics, operations research, physics, and computing. Vishnu has published 6 papers and 3 articles in fields including protein structural prediction, comparison of clinical guidelines cost-effectiveness in type 2 diabetes, development of programs to combat mental illness, cancer diagnosis with analytical chemistry and machine learning, and related areas.   He is also the founder of the CARES organization to support peer student wellness at college campuses, for which he won the Asoka Youth Changemaker award sponsored by Boehringer Ingelheim.  Vishnu has enthusiastically pursued science since his middle school days and has worked on demonstrating the possibilities of DNA computing, simulating protein folding, studying the genetic modifications in fruits and vegetables, and more. He has been recognized for his scientific research as an Intel Science Talent finalist, Google Science Fair Regional finalist, recipient of the American Institute of Aeronautics and Astronautics Excellence award for his work on epidemiology modeling.  Vishnu has interned at Caltech and Genentech, where he applied experimental techniques to purify and study protein behavior including dialysis, titration, chromatography for early stage drug development.  He was also selected as one of the two high school students to represent the western US Confucius Institute in Student Leaders Exchange Program in China as a non-native Mandarin speaker.

 

Hosted by: Sanjiv Sam Gambhir, M.D., Ph.D.
Sponsored by the PHIND Center and the Department of Radiology